Disclosed are a novel polypeptide and fusion proteins comprising a first segment having a lipidating sequence and a second segment having the sequence of a tumor-associated antigen The fusion proteins can be lipidated and expressed in bacterial cells Once administered to a subject, said fusion proteins induce immune responses against a tumor.
